CTLA4 and colorectal carcinoma: In addition, chemotherapeutic agents used to treat CRC may also alter the expression of key molecules in the TME, e.g., capecitabine was recently reported to suppress the expression of Cytotoxic T lymphocyte antigen-4 (CTLA-4) in CRC, with potential enhancement of immunotherapy (39).